Dupilumab modulates type II IL-4/IL-13 receptor-expressing immune cells in eosinophilic chronic rhinosinusitis

Yuri Sonobe, Tomohisa Iinuma, Kota Kokubo, Masahiro Kiuchi, Chiaki Iwamura, Masahiro Nemoto, Takahisa Hishiya, Atsushi Sasaki, Kaori Tsuji, Kanae Ohishi, Kohei Kusakari, Sayaka Sekino, Takuto Hiramoto, Rie Shinmi, Toshiyuki Koya, Atsushi Onodera, Motoko Y. Kimura, Shinichiro Motohashi, Syuji Yonekura, Toshinori Nakayama, Toyoyuki Hanazawa, Kiyoshi Hirahara

Open source

DOI: 10.1016/j.jaci.2026.10.021
Published: 2026-11
Container: Journal of Allergy and Clinical Immunology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jaci.2026.10.021,
  title = {Dupilumab modulates type II IL-4/IL-13 receptor-expressing immune cells in eosinophilic chronic rhinosinusitis},
  author = {Yuri Sonobe and Tomohisa Iinuma and Kota Kokubo and Masahiro Kiuchi and Chiaki Iwamura and Masahiro Nemoto and Takahisa Hishiya and Atsushi Sasaki and Kaori Tsuji and Kanae Ohishi and Kohei Kusakari and Sayaka Sekino and Takuto Hiramoto and Rie Shinmi and Toshiyuki Koya and Atsushi Onodera and Motoko Y. Kimura and Shinichiro Motohashi and Syuji Yonekura and Toshinori Nakayama and Toyoyuki Hanazawa and Kiyoshi Hirahara},
  year = {2026},
  journal = {Journal of Allergy and Clinical Immunology},
  doi = {10.1016/j.jaci.2026.10.021},
  url = {https://doi.org/10.1016/j.jaci.2026.10.021}
}

RIS

TY  - JOUR
TI  - Dupilumab modulates type II IL-4/IL-13 receptor-expressing immune cells in eosinophilic chronic rhinosinusitis
AU  - Yuri Sonobe
AU  - Tomohisa Iinuma
AU  - Kota Kokubo
AU  - Masahiro Kiuchi
AU  - Chiaki Iwamura
AU  - Masahiro Nemoto
AU  - Takahisa Hishiya
AU  - Atsushi Sasaki
AU  - Kaori Tsuji
AU  - Kanae Ohishi
AU  - Kohei Kusakari
AU  - Sayaka Sekino
AU  - Takuto Hiramoto
AU  - Rie Shinmi
AU  - Toshiyuki Koya
AU  - Atsushi Onodera
AU  - Motoko Y. Kimura
AU  - Shinichiro Motohashi
AU  - Syuji Yonekura
AU  - Toshinori Nakayama
AU  - Toyoyuki Hanazawa
AU  - Kiyoshi Hirahara
PY  - 2026
JO  - Journal of Allergy and Clinical Immunology
DO  - 10.1016/j.jaci.2026.10.021
UR  - https://doi.org/10.1016/j.jaci.2026.10.021
ER  -

APA

Sonobe, Y., Iinuma, T., Kokubo, K., Kiuchi, M., Iwamura, C., Nemoto, M., Hishiya, T., Sasaki, A., Tsuji, K., Ohishi, K., Kusakari, K., Sekino, S., Hiramoto, T., Shinmi, R., Koya, T., Onodera, A., Kimura, M. Y., Motohashi, S., Yonekura, S., Nakayama, T., Hanazawa, T., & Hirahara, K. (2026). Dupilumab modulates type II IL-4/IL-13 receptor-expressing immune cells in eosinophilic chronic rhinosinusitis. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.10.021

Source records

crossref · retrieved 2026-11-07T19:45:53.799Z